Why the Pro Medicus Limited (ASX:PME) share price is rocketing higher today

The Pro Medicus Limited (ASX:PME) share price has rocketed higher in morning trade after announcing a major deal with Partners Healthcare in the United States…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market may be sinking lower again today but the same cannot be said for the Pro Medicus Limited (ASX: PME) share price.

In morning trade the health imaging company's shares have rocketed over 10% higher to $10.11 following the announcement of a major new deal.

What was announced?

This morning Pro Medicus announced that its wholly-owned U.S. subsidiary, Visage Imaging, has signed a A$27 million, 7-year contract with Partners Healthcare.

Partners Healthcare is the largest health system in the state of Massachusetts and one of the largest and most respected health providers in North America.

According to the release, the contract is based on a transaction licensing model and will see Pro Medicus' Visage 7 technology implemented at Partners' two flagship hospitals, Massachusetts General Hospital and Brigham and Women's Hospital, eliminating their legacy PACS. It also includes scope to expand to other Partners network hospitals at a later date.

Pro Medicus CEO, Dr Sam Hupert, believes the deal is a milestone for Pro Medicus and that it is a testament to the quality of its technology.

He said: "Not only is it our biggest deal to date, there is the potential for further upside within the Partners network after this initial rollout is completed."

Before adding that these hospitals are: "two of the most prestigious medical institutions in North America renowned for their medical research, as well as their key roles as teaching hospitals for Harvard Medical School. The fact that both institutions selected Visage 7 as their platform of choice reinforces our view that Visage's leading edge technology is suitable for a broad range of clinical environments, including the most sophisticated and demanding users."

Should you invest?

While Pro Medicus' shares are certainly expensive, I believe deals like this demonstrate the enormous potential that the company has and why it could prove to be a great long-term buy and hold investment along with fellow healthcare technology companies Nanosonics Ltd (ASX: NAN) and Volpara Health Technologies Ltd (ASX: VHT).

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited, Pro Medicus Ltd., and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the week for investors.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Share Gainers

Why Catalyst Metals, Lynas, Polynovo, and St George Mining shares are pushing higher today

These shares are starting the week with a bang. But why?

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Gold

Guess which surging ASX gold share is leaping another 18% today on high-grade results

Investors are piling into this small-cap ASX gold share today. But why?

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been bidding up these four ASX 200 stocks this week. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Capstone Copper, Catalyst Metals, DroneShield, and Wildcat shares are rising today

These shares are having a strong finish to the week. But why?

Read more »

A man in a cardboard rocket ship and helmet zooms across the salt flats.
Materials Shares

Guess which surging ASX All Ords lithium share is smashing the benchmark again today

Investors are piling into this surging ASX lithium share again on Friday. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was yet another positive day for Australian investors.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Share Gainers

Why BHP, BlueScope, Catalyst Metals, and Ryman shares are storming higher today

These shares are having a better day than most on Thursday. What's going on?

Read more »